Skip to content

Comparison of Sufentanil Dosage in SPI-Enhanced Analgesia versus Conventional Analgesia

Comparison of Sufentanil Dosage in SPI-Enhanced Analgesia versus Conventional Analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088444
Enrollment
Unknown
Registered
2024-08-19
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

experimental group:SPI-guided analgesia

Sponsors

Department of Anesthesiology, Fujian University of Traditional Chinese Medicine Affiliated People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients undergoing gynecological laparoscopic surgery with ASA classification of I or II

Exclusion criteria

Exclusion criteria: 1.History of cardiovascular disease; 2.Severe liver or kidney dysfunction; 3.History of psychiatric or neurological disorders, alcohol abuse, or illicit drug use; 4.Medications affecting autonomic nervous regulation (e.g., beta-blockers, clonidine, etc.); 5.Pregnancy.

Design outcomes

Primary

MeasureTime frame
SPI;The dosage of remifentanil during surgery.;

Secondary

MeasureTime frame
Postoperative pain score;

Countries

China

Contacts

Public ContactLiu Wei

Department of Anesthesiology, Fujian University of Traditional Chinese Medicine Affiliated People's Hospital

308821545@qq.com+86 135 9939 3463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 9, 2026